AstraZeneca is developing a COVID-19 vaccine with the University of Oxford, and now, the company’s CEO is suggesting that the vaccine may be able to provide protection for one year. Paschal Soriot, the CEO of AstraZeneca was quoted by a Belgian radio station, saying, “We think that it will protect for about a year”.
However, he wasn’t clear on what happens next. Questions have been raised by members of the public on what happens after the one year elapses. The number one question on everyone’s mind is, would recipients need to get another dose of the vaccine?
AstraZeneca is working on only one vaccine and has already advanced to midstage testing. Efficacy trials are to begin soon and the CEO, Paschal Soriot was quoted by Reuters saying that the results of the clinical trials could be ready in August/September.
We are manufacturing in parallel. We will be ready to deliver from October if all goes well.
AstraZeneca has numerous deals lined up for them in light of a possible vaccine solution to the global crisis. Governments like Italy, France, Germany, Netherlands are allegedly lined up to order up to 300 million doses worth $843 million. Also the United Kingdom and the United States are not left out as they also allegedly have orders lined up for hundreds of millions of doses.
Low and middle income countries are not left out, as the company has signed a licensing agreement with the Serum Institute of India (SII) to provide one billion doses to these countries.